As of 2026-04-03, United Therapeutics Corporation (UTHR) trades at a current price of $564.81, marking a 0.96% decline from its previous closing level. This analysis examines key technical levels, recent market context, and potential short-term scenarios for the biotech stock, with no recent earnings data available as of publication. UTHR’s price action in recent weeks has been largely aligned with broader specialty biotech sector trends, with no material company-specific announcements driving i
UTHR Stock Analysis: United Therapeutics down 0.96% to $564.81 as biotech cools
UTHR - Stock Analysis
4427 Comments
1596 Likes
1
Erisa
Experienced Member
2 hours ago
I understood nothing but nodded anyway.
👍 290
Reply
2
Meadie
Power User
5 hours ago
This is exactly what I was looking for last night.
👍 226
Reply
3
Connstance
Loyal User
1 day ago
Free US stock earnings trajectory analysis and revision trends to understand fundamental momentum and analyst sentiment changes over time. We track how analyst estimates have been changing over time to gauge improving or deteriorating expectations for companies. We provide estimate trends, trajectory analysis, and revision tracking for comprehensive coverage. Understand momentum with our comprehensive earnings trajectory and revision analysis tools for momentum investing.
👍 125
Reply
4
Tomoya
Power User
1 day ago
Active sectors are attracting more attention, driving rotation and selective gains.
👍 102
Reply
5
Franck
Legendary User
2 days ago
Clear and concise analysis — appreciated!
👍 295
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.